RESOURCES

Novel fluorescent probes evaluated in an orthotopic pancreatic PDX model

Novel fluorescent probes evaluated in an orthotopic pancreatic PDX model

[EN] How to better predict the effect of cancer immunotherapy? Tailored-made humanized mouse models are the key solution!

Oncodesign and HitGen announce a strategic partnership in Integrated Drug Discovery Services (IDDS)

Bioanalytical challenges with BioChaperone® BC structures

We wish to develop and validate LC-MS/MS methods for the quantitation of both BioChaperone® BCXXX (Parent) and its truncated metabolite BCYYY inSprague-Dawley rat, Beagle dog and human plasma following the current international guidelines for industry?

[EN] How to trigger the immune response in anti-tumor therapy? A comprehensive in vitro to in vivo screening platform to identify ICD inducers

Oncodesign announces the creation of its new “Artificial Intelligence” Business Unit and appoints Stéphane Gerart as its Head

[EN] Simple services or solutions provider: what is the best option to support your drug discovery efforts at preclinical stage?

Outsourcing drug discovery represents a cost-effective opportunity to access specialized technologies & expert scientist resources and provide solutions

Single dose pharmacokinetics of intravenous 3,4-dihydroxyphenylacetic acid and 3-hydroxyphenylacetic acid in rats

Single dose pharmacokinetics of intravenous 3,4-dihydroxyphenylacetic acid and 3-hydroxyphenylacetic acid in rats

Oncodesign and Servier reach a key first milestone in their strategic partnership on LRRK2 inhibitors for Parkinson’s Disease

G Protein-Coupling of Adhesion GPCRs ADGRE2/EMR2 and ADGRE5/CD97, and Activation of G Protein Signalling by an Anti-EMR2 Antibody

G Protein-Coupling of Adhesion GPCRs ADGRE2/EMR2 and ADGRE5/CD97, and Activation of G Protein Signalling by an Anti-EMR2 Antibody

Development of a panel of breast cancer patient-derived xenograft models (PDX) with estrogen independence and/or acquired resistance to endocrine treatment

ADCs optimization led to a significant anti-tumoral activity in lymphoma and breast tumor xenograft mouse models